Showing results (51-60 of 177) with videos related to

Sort By:
Pageof 18
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2020
Cost-effectiveness of Antenatal Rescreening Among Pregnant Women for Hepatitis C in the United StatesAntoine Chaillon, Adriane Wynn, Tatyana Kushner, et al.
World Journal of Gastroenterology|July 1, 2024
Screening for metabolic dysfunction-associated fatty liver disease: Time to discard the emperor's clothes of normal liver enzymes?Chen-Xiao Huang, Xiao-Dong Zhou, Calvin Q Pan, et al.
Journal of Clinical Gastroenterology|August 24, 2016
Clinical Features of Chronic Hepatitis B in Treatment-naive Asian Patients With Positive HBeAg and Coexisting Precore and/or Basal Core Promoter MutationsCalvin Q Pan, Erhei Dai, Kalyan R Bhamidimarri, et al.
Hepatology Communications|September 13, 2022
Differential expression of hepatic cancer stemness and hypoxia markers in residual cancer after locoregional therapies for hepatocellular carcinomaMiran Kim, Kam Man Hui, Ming Shi, et al.
The American Journal of Medicine|September 3, 2025
A Practical Approach to the Diagnosis and Management of Hepatic EncephalopathyNancy Reau, David Bernstein, Paul Kwo, et al.
Plos One|March 6, 2014
Efficacy and safety of tenofovir disoproxil fumarate in Asian-Americans with chronic hepatitis B in community settingsCalvin Q Pan, Huy Trinh, Alan Yao, et al.
Frontiers in Pharmacology|January 23, 2024
Intestinal microbiome-targeted therapies improve liver function in alcohol-related liver disease by restoring bifidobacteria: a systematic review and meta-analysisXin Chi, Xiu Sun, Danying Cheng, et al.
World Journal of Gastroenterology|May 20, 2015
Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis BCalvin Q Pan, Sing Chan, Huy Trinh, et al.
International Journal of Public Health|August 30, 2020
Late presenters among minority patients with chronic hepatitis C infection in the USACalvin Q Pan, Charles Rabinovich, Vijay Gayam, et al.
Hepatology (Baltimore, Md.)|September 5, 2014
Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practiceHua Zhang, Calvin Q Pan, Qiumei Pang, et al.
Pageof 18